Back to results
US 7,763,650 B2Granted
Pharmaceutical compound and method
AssigneesMedipharma S.A., University Nacional De La Plata
InventorsLuis Bruno-Blanch, Sung Chin Moon
Life of this patent
Estimating the term…
Abstract
A new pharmaceutical compound for treating central nervous disorders, the compound comprising a therapeutically effective amount of valproic acid or pharmaceutically acceptable derivative thereof covalently bonded to myo-inositol. The invention also provides a composition, method for treating a patient and a method for obtaining the compound.
Claims9
A compound of the formula I:
- wherein:
- R1, R2, R3, R4, R5 and R6 are each independently selected from the group consisting of H;
- 2-propylpentanoyl;
- O-cyclohexyl-O;
- O-isopropylidene and PO3H2;
- with the proviso that at least one of the R1-6 groups is a 2-propylpentanoyl group,:
- including the position isomers, enantiomers
- thereof and excluding (±) 3, 6-di-O-valproyl-myo-inositol.
5 more elements
Dependencies are inferred from the claim text.